Abstract
In this issue of Blood, Hagner et al provide preclinical evidence that CC-122 might be active in both major molecular subtypes of diffuse large B-cell lymphoma (DLBCL).
Original language | English (US) |
---|---|
Pages (from-to) | 698-700 |
Number of pages | 3 |
Journal | Blood |
Volume | 126 |
Issue number | 6 |
DOIs |
|
State | Published - Aug 6 2015 |
ASJC Scopus subject areas
- Biochemistry
- Immunology
- Hematology
- Cell Biology